SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
Open Access
- 5 April 2013
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 27 (10), 2100-2102
- https://doi.org/10.1038/leu.2013.97
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomesLeukemia, 2013
- SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemiasLeukemia, 2013
- Recurrent SETBP1 mutations in atypical chronic myeloid leukemiaNature Genetics, 2012
- SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemiaJournal of Hematology & Oncology, 2012
- DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion StatusJournal of Clinical Oncology, 2011
- Cytogenetic risk stratification in chronic myelomonocytic leukemiaHaematologica, 2010
- De novo mutations of SETBP1 cause Schinzel-Giedion syndromeNature Genetics, 2010
- SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemiaBlood, 2010
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring SystemCancer, 2008
- Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patientsBlood, 2002